360 filings
Page 12 of 18
8-K
f60z4lyii
22 Jul 11
Other Events
12:00am
8-K
769t7
20 Jul 11
Dynavax Reports Second Quarter 2011 Financial Results
12:00am
8-K
jo4l2 p03v
3 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
c0rp4w3l52m
25 May 11
Data Expected within Eight Weeks
12:00am
8-K
oa65b tnb0w26adhi
19 May 11
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
i7w98snvq4o9oog
5 May 11
Dynavax Reports First Quarter 2011 Financial Results
12:00am
8-K
c0c1 v9d0a
20 Apr 11
Other Events
12:00am
8-K
v12tsbgix2jnhv
9 Mar 11
Dynavax Reports Fourth Quarter and Year End 2010 Financial Results
12:00am
8-K
p5vhdgd6
24 Feb 11
Dynavax Reports New Phase 1A and Phase 1B Data for Universal Flu Vaccine Candidate
12:00am
8-K
ku4ug
10 Jan 11
Dynavax Completes Enrollment for Phase 3 Study of Heplisav(tm) In Subjects with Chronic Kidney Disease
12:00am
8-K
h4ehcc
7 Jan 11
Departure of Directors or Certain Officers
12:00am
8-K
txe8kf0hnq4 7l
5 Jan 11
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
n6koqz2zf59oyg
23 Dec 10
Other Events
12:00am
8-K
8mtte8xe
7 Dec 10
Dynavax Reports Phase 1A Safety and Immunogenicity Results for Universal Flu Vaccine
12:00am
8-K
n3nd5487chf0
23 Nov 10
Departure of Directors or Certain Officers
12:00am
8-K
lgyvye0tjrp
8 Nov 10
Dynavax Reports 2010 Third Quarter Financial Results
12:00am
8-K
aexil5
28 Oct 10
Dynavax Announces Proposed Public Offering of Common Stock
12:00am
8-K
u9k8p
27 Oct 10
Results of Operations and Financial Condition
12:00am
8-K
68q4v0
13 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
85pyd 37nkwg
4 Oct 10
Entry into a Material Definitive Agreement
12:00am